Clinical Trials Logo
  1. Home
  2. Severe Infection
  3. NCT04923828
  4. Details
NCT04923828 Clinical Trial

Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections

Severe Infection Clinical Trial

Official title:
Children's Hospital of Fudan University

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04923828
Other study ID # fdpicu-21
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 31, 2023
Est. completion date December 31, 2026

Study information
Verified date February 2024
Source Children's Hospital of Fudan University
Contact Guoping Lu, Doctor
Phone 13788904150
Email 13788904150@163.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

To investigate PICUs in major cities in China by establishing a high-quality standardized clinical database of PICU inpatients Incidence, fatality rate, pathogen distribution, anti-infective treatment of community-acquired/nosocomial infections in inpatients.

Description:

All patients admitted to the PICU during January 1, 2016 to December 31 2025 were included in the study, and all patients were followed up until death or PICU withdrawal. To establish the standardized Access database collected patients' general information, infection, PICU treatment, catheter, and short-term Prognosis and other clinical data.

Recruitment information / eligibility
Status Recruiting
Enrollment 2000
Est. completion date December 31, 2026
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 1 Month to 16 Years
Eligibility Inclusion Criteria: - PICU patients with severe infection Exclusion Criteria: - Non-infected patient

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
China Children's Hospital of Fudan University Shanghai Shanghai

Sponsors (8)
Lead Sponsor Collaborator
Guoping Lu Anhui Provincial Children's Hospital, Ningbo Women & Children's Hospital, Qilu Children's Hospital of Shandong University, Shanghai Children's Hospital, Shanghai Children's Medical Center, The Children's Hospital of Zhejiang University School of Medicine, Xian Children's Hospital

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Pathogenic spectrum of PICU severe infection the 10 years of pathogenic spectrum of PICU severe infection 2016-2025
See also
  Status Clinical Trial Phase
Recruiting NCT04990908 - Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care Unit
Recruiting NCT05788861 - Invasive Group A Streptococcal Infection
Recruiting NCT05602324 - Nutritional Supplement for Patients With Severe Infection N/A
Active, not recruiting NCT02846298 - Evaluation of Pharmacokinetic / Pharmacodynamic Data and Interest Individualized Therapeutic Drug Monitoring Glycopeptides and β-lactam-aminoglycoside ICU
Recruiting NCT04650607 - Phage Safety Cohort Study
Recruiting NCT02167802 - Construction and Validation of a Tool for Automatic Identification of Care Pathways at Risk of Sub-optimality in the Management of Severe Infections in Children (DIABACT IV)
Completed NCT03145428 - Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis
Terminated NCT05210387 - Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections N/A
Recruiting NCT06260345 - CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit
Recruiting NCT06161870 - Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model Phase 4
Completed NCT04621539 - Validation of the Quick Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) in Obstetric Patients
Recruiting NCT06185920 - PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.
Completed NCT03588325 - Evaluation of MDW for Early Detection of Sepsis, Clinical Validity